CRP is commonly used clinically as a blood biomarker also in delirium [51] and in postoperative patients or patients with multiple traumas characterized by an early complement component 3 (C3) activation, represented by plasma C3 depletion and upregulation of cleaved forms of C3 (including C3a and C3b) [52]. This evidence concerns the gene C3 and delirium.